Equities

Faron Pharmaceuticals Oy

FARN:LSE

Faron Pharmaceuticals Oy

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)167.50
  • Today's Change5.00 / 3.08%
  • Shares traded4.11k
  • 1 Year change-1.47%
  • Beta2.1981
Data delayed at least 20 minutes, as of Feb 06 2026 15:56 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow in EURView more

In 2024, Faron Pharmaceuticals Oy increased its cash reserves by 38.21%, or 2.63m. Cash Flow from Financing totalled 25.82m or -- of revenues. In addition the company used 22.97m for operations while cash used for investing totalled 226.00k.
Cash flow per share-0.2505
Price/Cash flow per share--
Book value per share-0.1352
Tangible book value per share-0.1444
More ▼

Balance sheet in EURView more

Faron Pharmaceuticals Oy has a Debt to Total Capital ratio of 363.65%, a lower figure than the previous year's 648.66%.
Current ratio1.89
Quick ratio--
Total debt/total equity--
Total debt/total capital3.64
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.